Efficacy and Safety of Dutasteride and Finasteride in BPH Efficacy and Safety of Dutasteride and Finasteride in BPH
Are these two drugs safe and effective options for the treatment of benign prostatic hyperplasia?Translational Andrology and Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 11, 2022 Category: Consumer Health News Tags: Urology Journal Article Source Type: news

Aquablation Promising for Benign Prostatic Hyperplasia Aquablation Promising for Benign Prostatic Hyperplasia
Aquablation appears to be a safe and effective for treatment for lower-urinary-tract symptoms due to benign prostatic hyperplasia, regardless of prostate volume, new data show.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 9, 2022 Category: Consumer Health News Tags: Urology News Source Type: news

Association between benign prostatic hyperplasia and suicide in South Korea: a nationwide retrospective cohort study - Lee SU, Lee SH, So AH, Park JI, Lee S, Oh IH, Oh CM.
This study aims to examine the association benign prosta... (Source: SafetyLit)
Source: SafetyLit - March 14, 2022 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

FDA Approves Entadfi (finasteride and tadalafil) as a New Treatment for Benign Prostatic Hyperplasia
MIAMI, Dec. 13, 2021 (GLOBE NEWSWIRE)— Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancer, announced today that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 13, 2021 Category: Drugs & Pharmacology Source Type: news

Enlarged Prostate Doesn't Raise a Man's Odds for Cancer
Researchers report that having an enlarged prostate -- a condition called benign prostatic hyperplasia (BPH) -- may actually provide some protection from developing prostate cancer. (Source: WebMD Health)
Source: WebMD Health - August 25, 2021 Category: Consumer Health News Source Type: news

Enlarged Prostate Doesn't Raise a Man's Odds for Cancer: Study
WEDNESDAY, Aug. 25, 2021 -- Does having an enlarged prostate doom you to prostate cancer? Far from it, a new study suggests. Also called benign prostatic hyperplasia (BPH), the condition may actually provide some protection for men from developing... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 25, 2021 Category: General Medicine Source Type: news

Complication Rates After Surgery for BPH: Real-World Data Complication Rates After Surgery for BPH: Real-World Data
Data from a large real-world study of benign prostatic hyperplasia (BPH) therapies show that 2 of 3 minimally invasive surgical therapies give TURP a run for its money.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 13, 2021 Category: Consumer Health News Tags: Urology News Source Type: news

University Hospitals urologist designated as Center for Excellence for GreenLight ™ Laser Therapy
(University Hospitals Cleveland Medical Center) University Hospitals' Irina Jaeger, MD, received the prestigious designation as a Center of Excellence for GreenLight ™ Laser Therapy treatment - a minimally invasive outpatient procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms. Dr. Jaeger is a urologist at UH Richmond Medical Center and UH Brainard Medical Building in Lyndhurst. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 13, 2021 Category: International Medicine & Public Health Source Type: news

Sarcosine Distinguishes Prostate Cancer From BPH Sarcosine Distinguishes Prostate Cancer From BPH
This study assessed the diagnostic performance of plasma sarcosine as a complementary biomarker to PSA. How well does it distinguish malignancy from benign prostatic hyperplasia?Laboratory Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 10, 2021 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Medications for enlarged prostate linked to heart failure risk
(Wolters Kluwer Health) Widely used medications for benign prostatic hyperplasia (BPH) - also known as enlarged prostate - may be associated with a small, but significant increase in the probability of developing heart failure, suggests a study inThe Journal of Urology® , Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 22, 2021 Category: International Medicine & Public Health Source Type: news

Prostate Drugs Tied to Lower Risk for Parkinson's Prostate Drugs Tied to Lower Risk for Parkinson's
Men taking terazosin, doxazosin, or alfuzosin for benign prostatic hyperplasia, drugs that enhance glycolysis, had lower risk of incident PD vs tamsulosin, a similar drug that does not affect glycolysis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 9, 2021 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Source Type: news

Benign Prostatic Hyperplasia Can Be Protective Benign Prostatic Hyperplasia Can Be Protective
A patient presents with benign prostatic hyperplasia but due to a colovesical fistula, the condition actually improved his quality of life.Urologic Nursing (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 4, 2021 Category: Surgery Tags: Urology Journal Article Source Type: news

Urethral-sparing Robot-Assisted Simple Prostatectomy Preserves Ejaculatory Function Urethral-sparing Robot-Assisted Simple Prostatectomy Preserves Ejaculatory Function
Urethral-sparing robot-assisted simple prostatectomy (usRASP) preserves ejaculatory function while relieving lower-urinary-tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH), according to findings from a prospective study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 20, 2020 Category: Surgery Tags: Urology News Source Type: news

Investigation of suicidality and psychological adverse events in patients treated with finasteride - Nguyen DD, Marchese M, Cone EB, Paciotti M, Basaria S, Bhojani N, Trinh QD.
Importance: There is ongoing controversy about the adverse events of finasteride, a drug used in the management of alopecia and benign prostatic hyperplasia (BPH). In 2012, reports started emerging on men who had used finasteride and either attempted or co... (Source: SafetyLit)
Source: SafetyLit - November 14, 2020 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Mayo Clinic Radio podcast: 11/7/20
On the Mayo Clinic Radio podcast,?Dr. Mitchell Humphreys, a Mayo Clinic urologist, highlights prostate health and treatment options for?benign prostatic hyperplasia. Also on the program,?Dr. Francisco Lopez-Jimenez, a Mayo Clinic cardiologist, discusses sex after a?heart attack. And?Dr. Bruce Levy, a Mayo Clinic orthopedic surgeon, shares how his patients' experiences with lack of privacy during surgery [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 7, 2020 Category: Databases & Libraries Source Type: news